Impact of insulin or incretin hormones in reversing diabetic neuropathy in type 1 and type 2 diabetes mellitus
Date
2011
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Diabetes mellitus is a metabolic disorder where long-term complications including neuropathy, or nerve damage may arise. Peripheral neuropathy affects approximately 50% of total diabetic patients. Diabetic peripheral neuropathy (DPN) is a length-dependent
sensorimotor nerve disorder that can lead to pain, loss of feeling and motor ability. In this work we sought to determine whether insulin or exendin-4 will serve as neurotrophic and neuroprotective factors in both type 1 and type 2 diabetes and reverse DPN pathology. Our results showed that insulin or exendin-4 treatment improved some features of neuropathy in type 1 but not type 2 diabetes. Furthermore, a full reversal of DPN was not observed showing that current clinical dosing of insulin or exendin-4 therapy does not benefit neuropathy.
Description
Bibliography: p. 125-138
A few pages are in colour.
A few pages are in colour.
Keywords
Citation
Kan, M. (2011). Impact of insulin or incretin hormones in reversing diabetic neuropathy in type 1 and type 2 diabetes mellitus (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/4182